IGC Pharma Inc (IGC)
0.41
0.00 (0.00%)
USD |
NYAM |
Mar 28, 12:26
IGC Pharma Price: 0.41 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 0.408 | 0.409 | 0.3751 | 0.4065 | 338065.0 |
Mar 26, 2024 | 0.40 | 0.4354 | 0.353 | 0.399 | 1.021M |
Mar 25, 2024 | 0.3927 | 0.4169 | 0.376 | 0.40 | 530350.0 |
Mar 22, 2024 | 0.348 | 0.38 | 0.34 | 0.376 | 1.158M |
Mar 21, 2024 | 0.3426 | 0.357 | 0.3263 | 0.34 | 423114.0 |
Mar 20, 2024 | 0.38 | 0.476 | 0.3101 | 0.3445 | 2.464M |
Mar 19, 2024 | 0.356 | 0.43 | 0.34 | 0.3782 | 1.636M |
Mar 18, 2024 | 0.35 | 0.3699 | 0.335 | 0.339 | 906914.0 |
Mar 15, 2024 | 0.3478 | 0.3478 | 0.3245 | 0.3245 | 158577.0 |
Mar 14, 2024 | 0.33 | 0.343 | 0.33 | 0.3364 | 190070.0 |
Mar 13, 2024 | 0.33 | 0.3365 | 0.3251 | 0.333 | 129476.0 |
Mar 12, 2024 | 0.3342 | 0.349 | 0.3237 | 0.3251 | 542729.0 |
Mar 11, 2024 | 0.34 | 0.3495 | 0.33 | 0.3325 | 162826.0 |
Mar 08, 2024 | 0.3257 | 0.3495 | 0.3231 | 0.3331 | 214012.0 |
Mar 07, 2024 | 0.33 | 0.3398 | 0.3201 | 0.33 | 283899.0 |
Mar 06, 2024 | 0.339 | 0.3394 | 0.324 | 0.3284 | 249288.0 |
Mar 05, 2024 | 0.333 | 0.3499 | 0.3222 | 0.3353 | 215831.0 |
Mar 04, 2024 | 0.35 | 0.365 | 0.335 | 0.349 | 470285.0 |
Mar 01, 2024 | 0.3675 | 0.3675 | 0.3333 | 0.35 | 334985.0 |
Feb 29, 2024 | 0.355 | 0.4062 | 0.34 | 0.3446 | 867103.0 |
Feb 28, 2024 | 0.34 | 0.4999 | 0.33 | 0.349 | 3.933M |
Feb 27, 2024 | 0.3649 | 0.3699 | 0.3241 | 0.3422 | 457713.0 |
Feb 26, 2024 | 0.319 | 0.35 | 0.3003 | 0.349 | 1.110M |
Feb 23, 2024 | 0.28 | 0.32 | 0.274 | 0.303 | 1.606M |
Feb 22, 2024 | 0.289 | 0.2899 | 0.27 | 0.27 | 179478.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.2652
Minimum
Jan 23 2024
3.10
Maximum
Feb 10 2021
0.8813
Average
0.68
Median
Price Benchmarks
CEL-SCI Corp | 1.91 |
AIM ImmunoTech Inc | 0.47 |
NovaBay Pharmaceuticals Inc | 0.105 |
Protalix BioTherapeutics Inc | 1.275 |
Palatin Technologies Inc | 1.86 |
Price Related Metrics
PS Ratio | 18.90 |
Price to Book Value | 2.886 |
Earnings Yield | -63.41% |
Market Cap | 26.13M |